WealthStone’s DexCom DXCM Stock Holding History

WealthStone’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-16	Closed	-$599	–	213
2019 Q2	$599	Buy	+16	New	+$503	﹤0.01%	801

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

WealthStone's DXCM Position: Q3 2019 in Review

WealthStone sold out of DexCom (DXCM) in Q3 2019, closing a stake of 16 shares — an estimated $599 sold.

WealthStone first reported a position in DXCM in Q2 2019 and held it in 1 quarter. The position peaked at $599 in Q2 2019. 424 funds tracked by Wall St. Rank hold DXCM as of Q3 2019.

WealthStone reported no remaining DexCom position as of Q3 2019 after selling out during the quarter.
WealthStone sold 16 DexCom shares in Q3 2019, an estimated $599.
WealthStone first reported a position in DexCom in Q2 2019 and held it in 1 quarter.
WealthStone's DexCom position peaked at $599 in Q2 2019.
424 funds tracked by Wall St. Rank held DexCom as of Q3 2019.

Based on WealthStone's 13F filing for Q3 2019, filed 15 Nov 2019.